U.S. flag An official website of the United States government

On Oct. 1, 2024, the FDA began implementing a reorganization impacting many parts of the agency. We are in the process of updating FDA.gov content to reflect these changes.

  1. Home
  2. Vaccines, Blood & Biologics
  3. Cellular & Gene Therapy Products
  4. TECELRA
  1. Cellular & Gene Therapy Products

STN: 125789
Proper Name: afamitresgene autoleucel
Tradename: TECELRA
Manufacturer: Adaptimmune LLC
Indication:

  • Treatment of adults with unresectable or metastatic synovial sarcoma who have received prior chemotherapy, are HLA-A*02:01P, -A*02:02P, -A*02:03P, or -A*02:06P positive and whose tumor expresses the MAGE-A4 antigen as determined by FDA-approved or cleared Companion Diagnostic devices.

Product Information

Supporting Documents

 

Back to Top